Showing 901-910 of 20379 results for "".
Dyslipidemia in Children and Adolescents
https://reachmd.com/programs/lipid-luminations/dyslipidemia-children-and-adolescents/7551/Host Dr. Alan Brown welcomes Dr. Don Wilson, Endocrinologist at Cook Children's Health Care System, Fort Worth, Texas. Dr. Wilson will review dyslipidemia in children and adolescent patients. Key points of their discussion will cover the association between abnormal lipid levels in children and an iHair Concerns in the Post Menopausal Patient
https://reachmd.com/programs/clinicians-roundtable/hair-concerns-in-the-post-menopausal-patient/7217/Host Dr. Prathima Setty is joined by Dr. Bethanee J Schlosser, Assistant Professor in Dermatology and Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine, Chicago, IL. Dr. Schlosser discusses hair concerns and changes in post menopausal patients. She also addresses the iThe Difficult Patient Demystified
https://reachmd.com/programs/clinicians-roundtable/the-difficult-patient-demystified/4589/Over the years, many studies have examined the ‘difficult' patient encounter. Consistently, these studies indicate that physicians deem nearly 1 in 6 outpatient appointments to be an arduous visit. These challenging episodes are often time-consuming and may also lead to adverse outcomes. Though it iSurviving Sepsis: Early Diagnosis and Treatment
https://reachmd.com/programs/clinicians-roundtable/surviving-sepsis-early-diagnosis-and-treatment/4010/Who will benefit most from early intervention and treatment from the 750,000 patients hospitalized with sepsis each year? Dr Peter De Blieux, Pulmonary and Critical Care specialist from the Louisiana State University Health and Science Center, discusses early management and diagnosis including the iAdvances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
https://reachmd.com/programs/project-oncology/advances-in-follicular-lymphoma-treatment-car-t-cell-therapys-evolving-role/35485/This is a non-certified educational series produced and controlled by ReachMD. As the therapeutic landscape for follicular lymphoma continues to evolve, CAR T-cell therapy is emerging as a transformative option for select patients with relapsed or high-risk disease. But it also comes with a lot of iKeys to the Latest NLA Recommendations for Dyslipidemia Treatments
https://reachmd.com/programs/lipid-luminations/keys-to-the-latest-nla-recommendations-for-dyslipidemia-treatments/7064/What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all lipid-lowering medications in clinical use? Addressing these and other questions from the standpoing of recent NLA recommendations iEbola Virus: Controlling the Spread in Africa and the U.S.
https://reachmd.com/programs/primary-care-today/ebola-virus-controlling-the-spread-in-africa-and-the-us/7050/What are the differences in managing the Ebola virius in Africa versus the United States? It has been relatively controlled to date, but what are the major concerns in spreading? Host Dr. Brian McDonough welcomes special guest Dr. Kamar Adeleke, cardiologist in New Castle, Delaware, whose practice iUnpacking the Genetics of Friedreich’s Ataxia
https://reachmd.com/programs/neurofrontiers/genetics-friedreichs-ataxia/54669/Friedreich’s ataxia is a mitochondrial disorder driven by GAA repeat expansions in the frataxin gene, leading to impaired iron-sulfur cluster formation and cellular dysfunction. Tune in to hear Dr. Arnie Koeppen explain the genetic and epigenetic mechanisms underlying frataxin deficiency and their iIs Cardiac Resynchronization Beneficial?
https://reachmd.com/programs/focus-on-heart-health/is-cardiac-resynchronization-beneficial/4167/Does cardiac resynchronization therapy reduce the long term mortality risk in patients with heart failure. Host Dr. Larry Kaskel discusses with Dr. David Kass, a professor of cardiology at the Johns Hopkins University School of Medicine, the history of cardiac resynchronization and its application iPhysician Opportunity: Bringing a New Product to Market
https://reachmd.com/programs/clinicians-roundtable/physician-opportunity-bringing-a-new-product-to-market/3320/What does it take to develop a new product? How about an evidence based vitamin line? Today's guest, Cardiologist Dr. Seth Baum, was frustrated with the bags of supplements his patients would bring to him. They were taking too many supplements and not getting the right vitamins and nutrients. I